Mayer Davidson to Patient Selection
This is a "connection" page, showing publications Mayer Davidson has written about Patient Selection.
Connection Strength
0.069
-
Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
Score: 0.050
-
Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review. Prim Care Diabetes. 2009 May; 3(2):117-21.
Score: 0.019